Literature DB >> 30672625

Risks and challenges of CML management during pregnancy: Looking for a balanced decision.

Ekaterina Chelysheva1, Anna Turkina1.   

Abstract

Mesh：

Year:  2019        PMID： 30672625     DOI： 10.1111/ejh.13215

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  4 in total

Review 1.  Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similarities.

Authors:  Zehra Narlı Özdemir; Necati Alp Kılıçaslan; Musa Yılmaz; Ahmet Emre Eşkazan
Journal:  Int J Hematol       Date:  2022-09-05       Impact factor: 2.319

2.  Pregnancy outcomes in patients treated with bosutinib.

Authors:  Jorge E Cortes; Carlo Gambacorti-Passerini; Michael Deininger; Elisabetta Abruzzese; Liza DeAnnuntis; Tim H Brümmendorf
Journal:  Int J Hematol Oncol       Date:  2020-05-29

Review 3.  European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Authors:  A Hochhaus; M Baccarani; R T Silver; C Schiffer; J F Apperley; F Cervantes; R E Clark; J E Cortes; M W Deininger; F Guilhot; H Hjorth-Hansen; T P Hughes; J J W M Janssen; H M Kantarjian; D W Kim; R A Larson; J H Lipton; F X Mahon; J Mayer; F Nicolini; D Niederwieser; F Pane; J P Radich; D Rea; J Richter; G Rosti; P Rousselot; G Saglio; S Saußele; S Soverini; J L Steegmann; A Turkina; A Zaritskey; R Hehlmann
Journal:  Leukemia       Date:  2020-03-03       Impact factor: 11.528

Review 4.  Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations.

Authors:  Elisabetta Abruzzese; Michael Mauro; Jane Apperley; Ekaterina Chelysheva
Journal:  Ther Adv Hematol       Date:  2020-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.